Navigation Links
Metametrix Announces New Toxic Effects Profiles to Help Combat Growing Concerns About Toxicity and Health
Date:4/27/2009

DULUTH, Ga., April 27 /PRNewswire/ -- Daily exposure to toxins in the products we use for lifestyle convenience, such as plastics, adhesives, and insecticides, are creating a toxic load on our bodies contributing to chronic illnesses, mood disorders, allergies, and asthma. In light of increased awareness of our environmental exposures, Metametrix Clinical Laboratory (http://www.metametrix.com) announced today the release of three new testing profiles in the Toxic Effects Profiles product line.

"We are excited to release these new testing profiles that evolved from our acquisition of Accu-Chem Laboratories," says Dr. J. Alexander Bralley, CEO of Metametrix Clinical Laboratory. "Due to our everyday exposure to environmental toxins and pollutants, toxicity is becoming a major concern to overall health. These new profiles help identify areas of toxic exposure to assist practitioners in adding detoxification protocols for their patient treatment plans."

These toxicity tests are beneficial for patients who have been exposed to toxic chemicals from various sources including work environments, toxic spills, and industrial land, air, and water pollutants. Additionally, those patients with unexplained chronic conditions may consider testing for toxic burden. The new profiles include:

  • AccuChem Chlorinated Pesticides Profile - This profile helps identify exposure to chlorinated pesticides, such as DDT, that were used heavily in the agriculture industry and do not degrade in the environment. These toxins can cause or complicate a broad range of illnesses including allergies, asthma, cardiovascular disease, and cancer.

  • AccuChem Polychlorinated Biphenyls (PCBs) Profile - Measuring six common PCBs, this profile helps identify exposure to PCBs that are shown to cause health problems associated with neurobehavioral and immune system development. Lubricants formally used in transformers, capacitors, and electronic equipment were made with PCBs. Though banned since the 1970s, PCBs linger in the environment and are consumed by humans through the food chain.

  • AccuChem Volatile Solvents Profile - The volatile solvents profile determines possible exposure to common solvents in our working and living environments such as adhesives, glues, paints, paint thinners, gasoline vapors, and many more. These toxins may also be the underlying cause of many illnesses such as diabetes, fibromyalgia, brain fog, and mood disorders, to name a few.

"It is no longer a question of if we are burdened by toxins. It is a question of how burdened we are and whether these toxins are keeping us from the health we desire," states Dr. Walter J. Crinnion. "Finding the burden and removing the sources of toxicity are the critical steps in the road to recovery of health."

For 25 years, Metametrix Clinical Laboratory has been an industry leader in producing innovative, Next Generation Technologies for measuring nutritional insufficiencies, metabolic dysfunction, and microbial imbalances, as well as toxic influences on health. Metametrix is committed to applying the latest advances in testing services to functional and integrative medicine with a focus on quality, innovation, and education.

For Information: http://www.metametrix.com


'/>"/>
SOURCE Metametrix Clinical Laboratory
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Metametrix Announces Acquisition of Accu-Chem Laboratories
2. Metametrix Introduces the New Fat-Soluble Vitamins Profile - A Snapshot of Overall Nutrition
3. Metametrix Introduces the New Neopterin/Biopterin Profile
4. Warner Chilcott Announces Earnings Release Date and Conference Call For First Quarter 2009 Financial Results
5. Medical Nurse Training, Inc. Announces New Techniques to Achieve Tremendous Savings of Lives and Medical Costs of Over $200 Billion Annually
6. Time Domain Goes Global, Announces Worldwide Availability of its PLUS(TM) Ultra Wideband Real-Time Location System Sensor Platform
7. Neuisys Announces FDA Clearance of UroCARE
8. Inverness Medical Innovations Announces First Quarter 2009 Results
9. MesotheliomaHelp.net Announces Expanded Information on Lung Cancer and Mesothelioma Specialists
10. BELLUS announces Chief Financial Officer to depart effective May 22, 2009
11. Attorney General Eric Holder Honors Florida Doctor and Announces $4.7 Million in Recovery Act Funds for State
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2017)... , ... March 30, 2017 , ... ... the live audio conference “ Preventing Hospital Readmissions Through Discharge Planning ” with ... at 1:00 pm ET. This conference discusses strategies to prevent readmissions in light ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... squash, announced it has enlisted New York City-based sports and entertainment marketing firm ... and procure sponsorship opportunities for the Professional Squash Association (PSA), which includes first-time ...
(Date:3/29/2017)... ... March 30, 2017 , ... Sublime Naturals and its founder, Kathy Heshelow, ... Spice", it has been used for thousands of years. , "The West has caught ... of " Turmeric: How to Use it For Your Wellness. Overcome Inflammation, Enemy of ...
(Date:3/29/2017)... ... March 29, 2017 , ... Based ... into the challenges employers face in trying to balance both short-term and long-term ... programs? Adding to the growing complexity, companies are finding that the short-term ...
(Date:3/29/2017)... (PRWEB) , ... March 29, 2017 , ... ... Device Library for documenting and diagramming network and data center assets and audio-video ... NetZoom subscribers can request new equipment shapes for free and download shapes and ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... , Mar. 29, 2017 Research and Markets has ... at Proton Therapy Centers & Forecast" report to their offering. ... Proton Therapy Market in ... its market value in 2016. There are currently three proton therapy centers ... to treat more patients. In Italy , the first ...
(Date:3/29/2017)... 2017  Providence Medical Technology, Inc., an innovator ... two industry veterans to the commercial leadership team.  ... to lead Global Marketing, and Michael Scott ... and Mr. Scott have over 40 years of ... joins the company with over 22 years of ...
(Date:3/29/2017)... 2017  Glenmark Pharmaceuticals, a global pharmaceutical company, ... investigational fixed-dose combination of mometasone furoate (25 mcg) ... a nasal spray being studied for the treatment ... a recently completed Phase 3 trial assessing the ... versus mometasone, olopatadine or placebo. "We ...
Breaking Medicine Technology: